top headlines
Grifols has launched Fesilty in the USA, making the fibrinogen [...]
Cellares has secured a $50 million growth equity investment from [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Faeth Therapeutics has launched as a publicly traded oncology company [...]
ZoBio has launched a DNA-encoded library (DEL) hit discovery service [...]
VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]
oryzon-iadademstat-aml-alice2-frida-eha-2026 Oryzon Genomics has reported updated Phase 1b data from [...]
Sygnature Discovery has entered into a strategic collaboration with AI [...]
Medicus Pharma has submitted an investigational new drug application in [...]
